ALIM - Alimera Sciences GAAP EPS of -$0.75 misses by $0.35 revenue of $13.6M misses by $1.45M
- Alimera Sciences press release ( NASDAQ: ALIM ): Q3 GAAP EPS of -$0.75 misses by $0.35 .
- Revenue of $13.6M (+11.9% Y/Y) misses by $1.45M .
- On September 30, 2022, Alimera had cash and cash equivalents of approximately $5.5 million dollars, compared to $7.9 million in cash and cash equivalents on June 30, 2022.
For further details see:
Alimera Sciences GAAP EPS of -$0.75 misses by $0.35, revenue of $13.6M misses by $1.45M